Town Hall: Looking Back, Looking Forward

Renowned clinical kidney cancer researchers
will share a retrospective of 2021 breakthroughs,
along with a look forward at what we can expect
in 2022. Join us!

Speak Up for Research Funding

Every year, KidneyCAN sends advocates to Washington, D.C., to ask Congress to fund kidney cancer research. Our advocates are patients, caregivers, doctors, and researchers. Join us, and make a difference!

Handling the Holidays with Cancer

KidneyCAN gathered experts to share strategies for creating a “new normal” as you cope with kidney cancer during the holiday season.

Just diagnosed? Learn more.

A kidney cancer diagnosis can be scary and confusing. You’re not alone. KidneyCAN has put together resources to help you navigate a new diagnosis, your treatment options, and living well with cancer.

Kidney Cancer Research Summit 2021

KCRS21 took place on October 7-8, 2021. View video and slides of presentations to get the latest kidney cancer research news.

Making Progress Toward Cures

Our Goals

  • We provide education, resources, and support to kidney cancer patients and caregivers
  • We identify patients’ and researchers’ unmet needs
  • We engage and educate policymakers on the urgency of kidney cancer research funding
  • We urge Congress to fund kidney cancer research
  • We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
  • We provide direct funding to promising ideas
  • We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
  • We grow the community of kidney cancer researchers
  • We support the development of new treatments by educating patients on trial access and enrollment
  • We identify new unmet needs, set new goals, and keep working

Our Mission

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

NEWLY DIAGNOSED?

You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.  

BUILD A CARE TEAM

One of the best decisions you can make when facing kidney cancer is to choose an experienced medical team. We’ve put together resources including a checklist of questions for your doctor and a list of NCI comprehensive cancer centers.

For Patients

Advocacy

Research

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

Today, KidneyCAN advocates are on #CapitolHill requesting a $60M appropriation for the #KidneyCancer Research Program (KCRP) in FY24. This funding is crucial for advancing research and ...#acceleratingcures.

We're also asking Congress to allocate $50.9 billion to the #NIH, including $9.988 billion for the #NCI, to bolster #RCC research and development. Every dollar counts in the fight against cancer!

Today, KidneyCAN advocates are on #CapitolHill requesting a $60M appropriation for the #KidneyCancer Research Program (KCRP) in FY24. This funding is crucial for advancing research and ...#acceleratingcures.

We're also asking Congress to allocate $50.9 billion to the #NIH, including $9.988 billion for the #NCI, to bolster #RCC research and development. Every dollar counts in the fight against cancer!

Today, KidneyCAN advocates are on #CapitolHill requesting $60M for the #KidneyCancer Research Program (KCRP) in FY24 and $50.9 billion to the #NIH, including $9.988 billion for the #NCI. This funding... is critical for advancing research and #acceleratingcures!

#AdvocacyInAction

🚨 REMINDER: Last chance to 🗳️ in @ASCO Elections!

⏲️ DEADLINE: Monday, Dec. 4th at 3:00PM EST

Proud to support:
🌟The incomparable GU Oncology legend & ...mentor, @DrChoueiri!
🌟Our indefatigable #ASCOAdvocacy leader & past @ASCO Gov't Relations Committee Chair, @DrJasonWestin!

@montypal @LauraBukavinaMD @CaseUrology @scientistatlrge @FoxChaseCancer @NimaSharifiMD @dsui_miami_uro @lissmike @UTSA @EurUrolOncol @biorxivpreprint @spsutkaMD @DrChoueiri @NazliDizman ...@ZeynepZengin @ERPlimackMD @neerajaiims @shilpaonc @UroOnc We are very excited about our new trial @cityofhope in metastatic #RCC using a powerful combination of Nivo/Ipi with camu camu, a Brazilian berry, which has shown some remarkable efficacy in refractory melanoma

@kidneycan @KidneyCancer @EAUYAU_RenalCa @MOASC_Office @IKCCorg

Great advice from @Robert_Uzzo accepting the Joseph A. Smith Mentorship Award at #SUO23
✅Take Inventory
📉Embrace Failure
⏩Move Forward
🙏Be Grateful
Congratulations! So ...very well deserved.
#FoxChaseProud @FoxChaseCancer @FCUroOnc

It took @KyleBlumMD 6 years of work to develop this sarcomatoid RCC consortium. Willing to bet that breakthroughs regarding this aggressive RCC phenotype are going to culminate from his hard work!

When we formed KidneyCAN in 2016, the amount of money Congress allocated specifically for kidney cancer research was $0. Through advocacy, we’ve generated $135 million in research funding in five years.

Latest News

Voices of Resilience: Navigating Kidney Cancer in Veteran and Native American Communities

On the outskirts of Tulsa, Oklahoma, Maggie Burns stands as a testament to resilience and advocacy within the kidney cancer community. A caregiver to her husband, Ron Stanton, Maggie is a proud member of the Cherokee Nation and a retired IT professional. Maggie's life...

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at...

Dr. Moshe Ornstein: A Journey of Advocacy, Research, and Community in Kidney Cancer

This month, we asked Dr. Moshe Ornstein to share his insights in kidney cancer research and advocacy. He is a dedicated kidney cancer physician and researcher at the Cleveland Clinic. Dr. Ornstein completed his fellowship in Hematology & Oncology at the Cleveland...

From the Heart to the Hill: Advocating for Kidney Cancer Research Funding

Spring Advocacy : By the Numbers KidneyCAN is thrilled to announce the success of our Spring Advocacy Days event, which took place on March 13th in person in Washington, D.C., and on March 14th virtually. We are grateful for the 186 confirmed meetings with...

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community. 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

FALL ADVOCACY DAYS 2023 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER
kidney cancer and the military

KIDNEY CANCER & THE MILITARY

CLINICAL TRIALS →

IMMUNOTHERAPY →

RESEARCH UPDATES →

SURVIVORSHIP →

OPTIMIZING YOUR KIDNEY HEALTH →

HANDLING HOLIDAYS WITH CANCER →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Dr. Yousef Zakharia: “I Believe in Teamwork”

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News